Abstract:STING (Stimulator of Interferon Genes, also known as ERIS, MITA and MPYS) is an important adaptor protein in innate immunity.It plays a key role in cytosolic DNA mediated IFN production.STING is the direct sensor of cyclic dinucleotides(CDN) in cytosol, including c-di-GMP from pathogen and cGAMP synthesized by cGAS after DNA stimulating.After binding to and activated by CDNs, STING recruits and activates TBK1 and IRF3 by its C terminal tail.IRF3 is phosphorylated and then dimerize to enter nucleus, resulting in type I interferon (IFN) production.5,6-dimethylxanthenone-4-acetic acid (DMXAA) and 10-carboxymethyl-9-acridanone (CMA) were identified as antitumor/antiviral compounds which acted very well in mouse model but failed in human clinical trial.Further research showed that DMXAA and CMA bind to and activate mouse STING, but not human STING.To further investigate the mechanism of ligands' species selectivity, we studied on human STING(hSTING), rat STING(rSTING) and mouse STING(mSTING) by functional and structural analysis.We found that human and rat STINGs display more similar signaling profiles toward DMXAA and CMA than that of human and mouse STINGs, suggesting that rat is more suitable for preclinical testing of STING-targeted drugs.Previous research showed that a single point mutation in hSTING S162A renders hSTING sensitive to DMXAA.Through molecular dynamics simulations, we revealed how this single mutation alter the DMXAA-STING interaction.Compared to mutated systems, structural correlations in the interaction of STING with DMXAA are stronger, and the correlations are cross-protomers in the dimeric protein.Analyses on correlation coefficients lead to the identification of two key interactions that mediate the strong cross-protomer correlation in the DMXAA-STING interaction network: DMXAA-267T-162S* and 238R-260E*.These two interactions are partially and totally interrupted by the S162A and E260I mutations, respectively.Moreover, a smaller number of water molecules are displaced upon DMXAA binding to STING than that on binding to its mutants, leading to a larger entropic penalty for the former.Considering the sensitivity of STING and two of its mutants to DMXAA, a strong structural correlation appears to discourage DMXAA-STING binding.Such an observation suggests that DMXAA derivatives, which are deprived of hydrogen-bond interaction with both 162S* and 267T, are potential agonists of human STING.Taken together, our findings suggest better animal model for STING-targeted drugs and shed light on optimization of hSTING agonist.

STING inhibitors target the cyclic dinucleotide binding pocket

Targeting STING oligomerization with small-molecule inhibitors

Development of small molecule inhibitors/agonists targeting STING for disease

Structural Insights into a Shared Mechanism of Human STING Activation by a Potent Agonist and an Autoimmune Disease-Associated Mutation.

Bioactive Modulators Targeting STING Adaptor in Cgas-Sting Pathway

Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

Antitumor/antiviral Drugs Target on STING

Development of an orally bioavailable covalent STING inhibitor

STING, a promising target for small molecular immune modulator: A review

Medicinal chemistry perspective on cGAS-STING signaling pathway with small molecule inhibitors

Recent advances in the development of STING inhibitors: an updated patent review

Targeting STING oligomerization with licochalcone D ameliorates STING-driven inflammatory diseases

Agonists and Inhibitors of the Cgas-Sting Pathway

Small molecules targeting cGAS-STING pathway for autoimmune disease

Cyclopeptide Inhibitors Target the N‐Terminal Tail of STING and Alleviate Autoinflammation

The Cyclopeptide Astin C Specifically Inhibits the Innate Immune CDN Sensor STING.

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities

Human STING oligomer function is governed by palmitoylation of an evolutionarily conserved cysteine

Regulating STING in health and disease

Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy